Molecular genetics of colon cancer

Cancer and Metastasis Reviews

Volumn 16, Issue 1-2, 1997, Pages 67-79

  Tomlinson, Ian ^a   Ilyas, Mohammad ^b   Novelli, Marco ^c  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

colon cancer; evolution; genesis

Indexed keywords

COLON CANCER; HUMAN; MOLECULAR GENETICS; PRIORITY JOURNAL; REVIEW;

ADENOMA; CARCINOMA; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; DISEASE SUSCEPTIBILITY; GENE THERAPY; GENES, APC; GENES, P53; HUMANS; PREDICTIVE VALUE OF TESTS;

EID: 0030906347     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005744323215     Document Type: Review

References (119)

1. HMSO. Cancer Statistics. Registrations. England and Wales. London: HMSO, 1989
2. HMSO. Mortality Statistics. Cause. England and Wales. London: HMSO, 1992
3. Beart RW, Steele GJ, Menck HR et al.: Management and survival of patients with adenocarcinoma of the colon and rectum: a national survey of the Commission on Cancer. J Amer Coll Surg 181: 225-236, 1995
4. Dukes CE, Bussey HJR: The spread of cancer and its effect on prognosis. Cancer 12: 309-320, 1958
5. Jass JR, Love SB, Northover JMA: A new prognostic classification of rectal cancer. Lancet ii: 1303-1306, 1987
6. Morson B, Dawson I (eds): Morson and Dawson's gastrointestinal pathology. (Third ed.) Oxford: Blackwell Scientific Publications, 1990.
7. Powell SM, Zilz N, Beazer-Barclay Y et al.: APC mutations occur early during colorectal tumorigenesis. Nature 359: 235-237, 1992
8. Groden J, Thliveris A, Samowitz W et al.: Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66: 589-600, 1991
9. Kinzler KW, Nilbert MC, Su LK et al.: Identification of FAP locus genes from chromosome 5q21. Science 253:661-665, 1991
10. Miyoshi Y, Nagase H, Ando H et al.: Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet 1: 229-233, 1992
11. Solomon E, Voss R, Hall V et al.: Chromosome 5 allele loss in human colorectal carcinomas. Nature 328: 616-619, 1987
12. Miyaki M, Konishi M, Kikuchi-Yanoshita R et al.: Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumours. Cancer Res 54: 3011-3020, 1994
13. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990
14. Bodmer WF, Bailey CJ, Bodmer J et al.: Localization of the gene familial adenomatous polyposis on chromosome 5. Nature 328: 614-616, 1987
15. Howe GR, Benito E, Castelleto R et al.: Dietary intake of fiber and decreased risk of cancers of the colon and rectum; evidence from the combined analysis of 13 case-control studies. J Natl Cancer Inst 84(24): 1887-1896, 1992
16. Joslyn G, Richardson DS, White R, Alber T: Dinier formation by an N-terminal coiled coil in the APC protein. Proc Natl Acad Sci USA 90: 11109-11113, 1993
17. Baeg GH, Matsumine A, Kuroda T et al.: The tumour suppressor gene product APC blocks cell cycle progression from G0/G1 to S phase. EMBO J 14: 5618-5625, 1995
18. Su LK, Vogelstein B, Kinzler KW: Association of the APC tumor suppressor protein with catenins. Science 262:1734-1737, 1993
19. Rubinfeld B, Souza B, Albert I et al.: Assocation of the APC gene product with beta-catenin. Science 262: 1731-1734, 1993
20. Browne S, Williams A, Hague A, Butt A et al.: Loss of apc protein expressed by human colonie epithelial-cells and the appearance of a specific low-molecular-weight form is associated with apoptosis in vitro. Int J Cancer 59: 56-64, 1994
21. Burchill SA: The tumour suppressor APC product is associated with cell adhesion. Bioassays 16: 225-227, 1994
22. Munemitsu S, Souza B, Miller O et al.: The APC gene product associates with microtubules in vivo and promotes their assembly in vitro. Cancer Res 54: 3676-3681, 1994
23. Spirio L, Olschwang S, Groden J et al.: Alleles of the APC gene: an attenuated form of familial polyposis. Cell 75: 951-957, 1993
24. Friedl W, Meuschel S, Caspari R et al.: Attenuated familial adenomatous polyposis due to a mutation in the 3′ part of the APC gene. A clue for understanding the function of the APC protein. Hum Genet 97: 579-584, 1996
25. Samowitz WS, Thliveris A, Spirio LN, White R: Alternatively spliced adenomatous polyposis coli (APC) gene transcripts that delete exons mutated in attenuated APC. Oncogene 55: 3732-3734, 1995
26. Novelli MR, Williamson JA, Tomlinson IPM et al.: Polyclonal origin of colonie adenomas in an XO/XY patient with FAP. Science 272: 1187-1190, 1996
27. Su LK, Kinzler KW, Vogelstein BV et al.: Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256: 668-670, 1992
28. Moser AR, Luongo C, Gould KA et al.: ApcMin: a mouse model for intestinal and mammary tumorigenesis. Eur J Cancer 31A: 1061-1064, 1995
29. MacPhee M, Chepenik KP, Liddell RA et al.: The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia. Cell 81: 957-966, 1995
30. Tomlinson IPM, Neale K, Talbot IC et al.: A modifying locus for familial adenomatous polyposis may be present on chromosome 1p35-p36. J Med Genet 33: 268-273, 1996
31. Riggins GJ, Markowitz S, Wilson JK et al.: Absence of secretory phospholipase A2 gene alterations in human colorectal cancer. Cancer Res 55(22): 5184-5186, 1995
32. Leach FS, Nicolaides NC, Papadopoulos N et al.: Mutations of a mutS homolog in heriditary nonpolyposis colorectal cancer. Cell 75: 1215-1225, 1993
33. Lindblom A, Tannergard P, Werelius B, Nordenskjold M: Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer. Nat Genet 5: 279-282, 1993
34. Fishel R, Lescoe MK, Rao MR et al.: The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75: 1027-1038, 1993
35. Aaltonen LA, Peltomaki P, Leach FS et al.: Cues to the pathogenesis of familial colorectal cancer. Science 260: 812-816, 1993
36. Tomlinson IPM, Novelli MR, Bodmer WF: The mutation rate and cancer. Proc Natl Acad Sci USA 1996
37. Liu B, Nicolaides NC, Markowitz S et al.: Mismatch repair gene defects in sporadic colorectal cancers with microsatellile instability. Nat Genet 9: 48-55, 1995
38. Connell WR, Talbot IC, Harpaz, N et al.: Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis. Gut 35(10): 1419-1423, 1994
39. Ilyas M, Tomlinson IPM: Genetic pathways in colorectal cancer. Histopathol 28: 389-399, 1996
40. Redston M, Papadipoulos N, Caldas C et al.: Common occurrence of APC and K-ras mutation in the spectrum of colitis-associated neoplasias. Gastroenterol 108: 383-392, 1995
41. Tarmin L, Yin J, Harpaz N et al.: Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms. Cancer Res 55: 2035-2038, 1995
42. Burmer GC, Crispin DA, Kolli VR et al.: Frequent loss of a p53 allele in carcinomas and their precursors in ulcerative colitis. Cancer Commun 3: 167-172, 1991
43. Brentnall TA, Crispin DA, Rabinovitch PS et al.: Mutations in the p53 gene: An early marker of neoplastic progression in ulcerative colitis. Gastroenterol 107: 369-378, 1994
44. Tops CM, van der Klift HM, van der Luijt RB et al.: Non-allelic heterogeneity of familial adenomatous polyposis. Amer J Med Genet 47: 563-567, 1993
45. Whitelaw SC, Murday VA, Tomlinson IPM et al.: Clinical and molecular features of the Hereditary Mixed Polyposis Syndrome. Gastroenterol 1997, in press
46. Hemminki A, Tomlinson IPM, Markie D et al.: Localisation of a susceptibility focus for Peutz-Jeghers syndrome using comparative genomic hybridisation and targeted linkage analysis. Nat Genet 15: 87-90, 1997
47. Jacoby RF, Schlack S, Cole CE, Marshall DJ, Kuhlman G et al.: Identification of a juvenile polyposis tumor-suppressor gene locus (JP1) and demonstration of its deletion in subepithelial cells. Gastroenterol 110: A535, 1996
48. Thomas HJW, Whitelaw SC, Cottrell SE et al.: Genetic mapping of the Hereditary Mixed Polyposis Syndrome to chromosome 6q. Amer J Hum Genet 58: 770-776, 1996
49. Nelen MR, Padberg GW, Peeters EAJ et al.: Localization of the gene for Cowden disease to chromosome 10q22-23. Nat Genet 13: 114-116, 1996
50. Nowell PC: The clonal evaluation of tumor cell populations. Science 194: 23-28, 1976
51. Tomlinson IPM: Evolutionary theory and cancer. Trends Ecol Evol 8: 107-110, 1993
52. Shepherd JA: Regression phenomenon in familial polyposis. Proc Roy Soc Med 65: 169, 1972
53. Giardello FM: Sulindac and polyp regression. Cancer Met Rev 13: 279-283, 1994
54. Bos JL: The ras gene family and human carcinogenesis. Mutat Res 195: 255-271, 1988
55. Smith AJ, Stern HS, Penner M et al.: Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res 54: 5527-5530, 1994
56. Burmer GC, Levine DS, Kulander BG et al.: c-Ki-ras mutations in chronic ulcerative colitis and sporadic colon carcinoma. Gastroenterol 99: 416-420, 1990
57. Minamoto T, Yamashita N, Ochiai A et al.: Mutant K-ras in apparently normal mucosa of colorectal cancer patients. Its potential as a biomarker of colorectal tumorigenesis. Cancer 75(6 Suppl): 1520-1526, 1995
58. Pretlow TP: Aberrant crypt foci and K-ras mutations: earliest recognised players or innocent bystanders in colon carcinogenesis? Gastroenterol 108: 600-603, 1995
59. Bird RP: Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett 93: 55-71, 1995
60. Jen J, Kim H, Piantadosi S et al.: Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 331: 213-221, 1994
61. Vogelstein BV, Fearon ER, Hamilton SR et al.: Genetic alterations during colorectal tumour development. N Engl J Med 319: 525-532, 1988
62. Knudson AG: Hereditary cancer: two hits revisited. J Cancer Res Clin Oncol 122: 135-140, 1996
63. Kinzler KW, Nilbert MC, Vogelstein B et al.: Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Science 251: 1366-1370, 1991
64. Curtis LJ, Bubb VJ, Gledhill S, Morris RG, Bird CC, Wyllie AH: Loss of heterozygosity of MCC is not associated with mutation of the retained allele in sporadic colorectal cancer. Hum Mol Genet 3: 443-446, 1994
65. Hedrick L, Cho KR, Fearon ER, Wu TC, Kinzler KW, Vogelstein B: The DCC gene product in cellular differentiation and colorectal tumorigenesis. Genes Dev 8: 1174-1183, 1994
66. Thiagalingam S, Lengaver C, Leach FS et al.: Evaluation of candidate tumor suppressor genes on chromosome 18 in colorectal cancers. Nat Genet 13: 343-346, 1996
67. Baker SJ, Preisinger AC, Jessup JM et al.: p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 50: 7712-7722, 1990
68. Cunningham J, Lust JA, Schaid DJ et al.: Expression of p53 and allelic loss in colorectal carcinoma. Cancer Res 52: 1974-1980, 1992
69. Kawasaki Y, Monden T, Morimoto H et al.: Immunohistochemical study of p53 expression in microwave-fixed, paraffin-embedded sections of colorectal carcinoma and adenoma. Am J Pathol 97: 244-249, 1992
70. Lane DP: Cancer. p53, guardian of the genome. Nature 358: 15-16, 1992
71. Donehower LA, Bradley A: The tumor suppressor p53. Biochim Biophys Acta 1155: 181-205, 1993
72. Carder P, Wyllie AH, Purdie CA et al.: Stabilised p53 facilitates aneuploid clonal divergence in colorectal cancer. Oncogene 8: 1397-1401, 1993
73. Krawczak M, Smith SB, Schmidtke J et al.: Somatic spectrum of cancer-associated single basepair substitutions in the TP53 gene is determined mainly by endogenous mechanisms of mutations and by selection. Hum Mutat 5: 48-57, 1995
74. Ohta M, Inoue H, Cotticelli MG et al.: The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84: 587-597, 1996
75. Okamoto A, Demetrick DJ, Spillare EA et al.: Mutations and altered expression of p16INK4 in human cancer. Proc Natl Acad Sci USA 91: 11045-11049, 1994
76. Herman JG, Merlo A, Mao L et al.: Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 55: 4525-4530, 1995
77. Gonzalez ZM, Bender CM, Yang AS et al.: Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 55: 4531-4535, 1995
78. Leister I, Weith A, Bruderlein S et al.: Human colorectal cancer: high frequency of deletions at chromosome 1p35. Cancer Res 50: 7232-7225, 1990
79. Praml C, Finke LH, Herfarth C et al.: Deletion mapping defines different regions in 1p34.2-pter that may harbor genetic information related to human colorectal cancer. Oncogene 11(7): 1357-1362, 1995
80. Wildrick D, Alfaro S, Gope R, Boman B: A study of chromosome-6 allele loss in human colorectal carcinomas. Anticancer Res 12: 1717-1719, 1992
81. Fujiwara Y, Emi M, Ohata H et al.: Evidence for the presence of two tumor suppressor genes on chromosome 8p for colorectal carcinoma. Cancer Res 53: 1172-1174, 1993
82. Cunningham C, Dunlop MG, Wyllie AH, Bird CC: Deletion mapping in colorectal cancer of a putative tumour suppressor gene in 8p22-p21.3. Oncogene 8: 1391-1396, 1993
83. Young J, Leggett B, Ward M et al.: Frequent loss of heterozygosity on chromosome-14 occurs in advanced colorectal carcinomas. Oncogene 8: 671-675, 1993
84. Yana I, Kurahashi H, Nakamori S et al.: Frequent loss of heterozygosity at telomeric loci on 22q in sporadic colorectal cancers. Int J Cancer 60: 174-177, 1995
85. Houldsworth J, Chaganti RS: Comparative genomic hybridisation: an overview. Am J Pathol 145: 1253-1260, 1994
86. Liu B, Parsons R, Papadopoulos N et al.: Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 2: 169-174, 1996
87. Kim H, Jen J, Vogelstein B, Hamilton SR: Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol 145: 148-156, 1994
88. Young J, Leggett B, Gustafson C et al.: Genomic instability occurs in colorectal carcinomas but not in adenomas. Hum Mutat 2: 351-354, 1993
89. Ilyas M, Tomlinson IPM, Novelli MR et al.: Clinico-pathological features and p53 expression in left-sided sporadic colorectal cancers with and without microsatellite instability. J Pathol 179:370-375, 1996
90. Tomlinson IPM, Bodmer WF: Failure of programmed cell death and differentiation as causes of tumors: some simple mathematical models. Proc Natl Acad Sci USA 92: 11130-11134, 1995
91. Tomlinson IPM, Bodmer WF: Models of non-autonomous interactions of tumour cells. Brit J Cancer 1997, in press
92. Leek RD, Harris AL, Lewis CE: Cytokine networks in solid human tumors: regulation of angiogenesis. J Leukoc Biol 56: 423-435, 1994
93. Browning MJ, Krausa P, Rowan A et al.: Loss of human leukocyte antigen expression on colorectal tumor cell lines: implications for anti-tumor immunity and immunotherapy. J Immunother 14: 163-168, 1993
94. Linn SC, Giaccone G: MDR1/P-glycoprotein expression in colorectal cancer. Eur J Cancer 31A: 1291-1294, 1995
95. Nuovo GJ: In situ PCR: protocols and applications. PCR Methods Appl 4:S151-167, 1995
96. Pignatelli M, Liu D, Nasim MM et al.: Morphoregulatory activities of E-cadherin and beta-1 integrins in colorectal tumour cells. Br J Cancer 66: 629-634, 1992
97. Kinsella AR, Lepts GC, Hill CL, Jones M: Reduced E-cadherin expression correlates with increased invasiveness in colorectal carcinoma cell lines. Clin Exp Metastasis 12: 335-342, 1994
98. Dorudi S, Sheffield JP, Poulsom R et al.: E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. Am J Pathol 142: 981-986, 1993
99. Ilyas M, Tomlinson IPM, Hanby A et al.: Allele loss, replication errors and loss of expression of E-cadherin in colorectal cancers. Gut 1997, in press
100. De Bruin PAF, Griffioen G, Verspaget HW et al.: Plasminogen activator profiles in neoplastic tissues of the human colon. Cancer Res 48: 4520-4524, 1988
101. Sier CFM, Vloedgraven HJM, Griffioen G et al.: Plasminogen activators and inhibitor type 1 in neoplastic colonie tissue from patients with familial adenomatous polyposis. Br J Cancer 71: 393-396, 1995
102. MacDonald NJ, de la Rosa A, Steeg PS: The potential roles of nm23 in cancer metastasis and cellular differentiation. Eur J Cancer 31A: 1096-1100, 1995
103. Martinez JA, Prevot S, Nordlinger B et al.: Overexpression of nm23-H1 and nm23-H2 genes in colorectal carcinomas and loss of nm23-H1 expression in advanced tumour stages. Gut 37: 712-720, 1995
104. Iacopetta B, DiGrandi S, Dix B, Haig C, Soong R, House A: Loss of heterozygosity of tumour suppressor gene loci in human colorectal carcinoma. Eur J Cancer 30A: 664-670, 1994
105. Cawkwell L, Lewis FA, Quirke P: Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction. Br J Cancer 70: 813-818, 1994
106. Campo E, Miquel R, Jares P et al.: Prognostic-significance of the loss of heterozygosity of nm23-h1 and p53 genes in human colorectal carcinomas. Cancer 73: 2913-2921, 1994
107. Ichikawa W: Positive relationship between expression of CD44 and hepatic metastases in colorectal cancer. Pathobiology 62: 172-179, 1994
108. Plummer SJ, Casey G: Are we any closer to genetic testing for common malignancies? Nat Med 2: 156-158, 1996
109. Lynch HT, Smyrk T, Jass JR: Hereditary non-polyposis colorectal cancer and colonie adenomas: aggressive adenomas? Semin Surg Oncol 11: 406-410, 1995
110. Rhodes M, Bradburn DM: Overview of screening and management of familial adenomatous polyposis. Gut 33: 125-131, 1992
111. Lynch HT, Smyrk T, Lynch JF: Overview of natural history, pathology, molecular genetics and management of HNPCC (Lynch syndrome). Int J Cancer 69: 38-43, 1996
112. Lynch HT, Smyrk TC, Watson P et al.: Genetics, natural history, tumor spectrum, and pathology of hereditary non-polyposis colorectal cancer: an updated review. Gastroenterol 104: 1535-1549, 1993
113. Jass JR: Colorectal adenomas in surgical specimens from subjects with hereditary non-polyposis colorectal cancer. Histopathol 27: 263-267, 1995
114. Jass JR, Stewart SM, Stewart J, Lane MR: Hereditary non-polyposis colon cancer - morphologies, genes and mutations. Mutat Res 310: 125-133, 1994
115. Percesepe A, Anti M, Roncucci L et al.:The effect of family size on estimates of the frequency of hereditary non-polyposis colorectal cancer. Br J Cancer 72: 1320-1323, 1995
116. Duffy MJ: Can molecular markers now be used for early diagnosis of malignancy? Clin Chem 41: 1419-1413, 1995
117. Leather AJ, Gallegos NC, Kocjan G et al.: Detection and enumeration of circulating tumour cells in colorectal cancer. Br J Surg 80: 777-780, 1993
118. Lowe SW, Bodis S, McClatchey A et al.: p53 status and the efficacy of cancer therapy in vivo. Science 266: 807-810, 1994
119. Hargest R, Williamson R: Expression of the APC gene after transfection into a colonie cancer cell line. Gut 37: 826-829, 1995